Page last updated: 2024-10-22

amiodarone and Central Nervous System Origin Vertigo

amiodarone has been researched along with Central Nervous System Origin Vertigo in 2 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Research Excerpts

ExcerptRelevanceReference
"Paraesthesiae, ataxia, vertigo and tremor were the most common (7-9%)."1.28Survey of neurological problems with amiodarone in the New Zealand Intensive Medicines Monitoring Programme. ( Coulter, DM; Edwards, IR; Savage, RL, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arbusow, V1
Strupp, M1
Brandt, T1
Coulter, DM1
Edwards, IR1
Savage, RL1

Other Studies

2 other studies available for amiodarone and Central Nervous System Origin Vertigo

ArticleYear
Amiodarone-induced severe prolonged head-positional vertigo and vomiting.
    Neurology, 1998, Volume: 51, Issue:3

    Topics: Aged; Amiodarone; Humans; Male; Posture; Vertigo; Vestibular Diseases; Vomiting

1998
Survey of neurological problems with amiodarone in the New Zealand Intensive Medicines Monitoring Programme.
    The New Zealand medical journal, 1990, Mar-14, Volume: 103, Issue:885

    Topics: Amiodarone; Ataxia; Humans; Nervous System Diseases; New Zealand; Paresthesia; Product Surveillance,

1990